# The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation

> **NCT02393807** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF 06260414 solid dose formulation
- **DRUG:** PF-06260414 nanosuspension

## Key facts

- **NCT ID:** NCT02393807
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02393807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02393807, "The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02393807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*